Breaking News!

Loading...

Friday, September 19, 2014

Washington, D.C., Voters Strongly Support Marijuana Legalization

 
Posted:
Washington, D.C., voters appear to be ready to legalize marijuana, according to a new poll that puts support at 65 percent. The NBC4/Washington Post/Marist poll's finding that district voters support legalization by amost a 2-1 margin “is the highest support ever for a marijuana legalization ballot initiative,” Adam Eidinger, chair of D.C. Cannabis Campaign, the group backing the legalization measure, said in a statement. “It vindicates the work of this campaign so far, but we still have more work to do turning out the vote come Election Day.”

On Nov. 4, D.C. voters will decide Initiative 71, which would legalize adult marijuana use, possession of up to two ounces, and home cultivation of up to six marijuana plants for personal use. The sale of marijuana would remain illegal. The D.C. Council is considering a separate bill that would allow the regulation and taxation of marijuana. The new poll suggests D.C. will join Washington state and Colorado in legalizing recreational marijuana. Just days before Washington state voters legalized recreational marijuana in 2012, Public Policy Polling found 53 percent support for the measure. The day before Colorado voters approved marijuana for recreational use by adults, PPP found 52 percent support.

“Voters are relating to the message that legalization will end D.C.’s rampant discrimination when it comes marijuana enforcement," said Dr. Malik Burnett, D.C. Policy Manager for the Drug Policy Alliance, in a statement. According to the Washington Lawyers' Committee, arrest statistics from 2009 to 2011 revealed that nine out of 10 people arrested for drugs in Washington were black, though blacks make up just slightly more than half of the city's population. Yet government surveys show that blacks are no more likely than whites to use the drug. A marijuana activist criticized The Washington Post for editorializing against legalization. "At the very moment this Washington Post poll was in the field, the paper's own editorial board was circulating a 'Reefer Madness'-style, error-laden screed urging D.C. voters to reject legalization," Marijuana Majority's Tom Angell told

The Huffington Post. A Sunday Post editorial urged D.C. voters to "reject the rush to marijuana." "It looks like that didn't work," Angell said of the editorial. "No matter how hard prohibitionists try to spread scare stories about legalization, poll after poll confirms that this is a mainstream issue supported by a growing majority of the public." Kevin Sabet, co-founder of anti-legalization group Project SAM, said he sees the poll numbers differently. "I think it represents the fact that the 'Yes' side has spent hundreds of thousands of dollars raised outside the District on its messaging," Sabet said. "As voters hear more about why marijuana and marijuana businesses are not good for the District, I expect the gap to narrow."

The ballot measure builds on several recent moves to remove restrictions on marijuana in Washington. The District's first medical marijuana dispensary opened last year. Earlier this year, the D.C. Council decriminalized the possession of an ounce or less of marijuana. The District legalized marijuana for medical use in 2010. Twenty-three states also have legalized medical marijuana. Voters in three states will decide on new marijuana laws in November. Oregon and Alaska voters will cast ballots on the legalization of recreational marijuana, while voters in Florida will decide on a medical marijuana ballot measure.

http://www.huffingtonpost.com/2014/09/18/washington-dc-marijuana-legalization_n_5845942.html

Medbox, Inc. Announces the Launch of its New Investor Relations Website

 
 
LOS ANGELES, Sept. 10, 2014 /NEWS.GNOM.ES/ — Medbox, Inc. (OTCQB: MDBX) (www.medbox.com), a leading dispensary infrastructure/licensing specialist, patented technology provider, and partner to the cannabis industry, unveiled its new Investor Relations website. The site, www.medbox.com, incorporates numerous features to make browsing for investment information a much faster and informative experience for the Company’s current and potential investors.The new Investor Relations section features immediate posting of the Company’s press releases as they are issued, as well as the automated posting of SEC filings, XBRL data, Insider Section 16 filings and detailed annual as well as quarterly financial statements. Stock information data such as quotes, charts and historical prices are updated on demand with a 20-minute delay and the Company’s financial tear sheet is updated daily after the market close. There is also an IR calendar featuring upcoming events, conference calls, investor presentations, CEO interviews and media coverage as well as corporate videos and an up-to-date frequently asked question section.

Guy M. Marsala, Medbox’s President, Chief Executive Officer and Chairman of the Board of Directors said, “A significant part of our mission is presenting current and potential investors with the information they want in the quickest and most organized way. We believe our new IR website advances this goal by presenting our investor information in an attractive and easy-to-access format. Mr. Marsala continued, “A priority for the IR website is to maximize corporate transparency for the benefit of our investors and we are confident that the new IR website succeeds in providing this transparency. Furthermore, the IR website allows us to archive an extensive range of corporate materials and information that can be easily searched and accessed by any investor at any time.” 
Medbox engaged Equisolve, Inc. to design, develop and provide ongoing management for the new IR website.  Equisolve is the leading company delivering cutting edge communications solutions for public companies by integrating the company’s corporate website and IR website on a single platform.
Make sure you are first to receive timely information on Medbox when it hits the newswire. Sign up for Medbox’s email news alert system today at: www.medbox.com
About Medbox, Inc. Medbox (http://www.medbox.com) is the leading dispensary infrastructure and licensing specialist, patented technology provider, and partner to the cannabis industry. Headquartered in Los Angeles, CA, Medbox, through its wholly owned subsidiary, Medicine Dispensing Systems, offers its patented systems, software and consulting services to pharmacies, alternative medicine dispensaries and local governments in the U.S. In addition, through its wholly owned subsidiary, Vaporfection International, Inc. (www.vaporfection.com), the company offers an industry award winning medical vaporizer product. Medbox, through its newly established subsidiaries, is in development of the following ancillary services tailored to the alternative medicine industry: merchant services and armored transport for cash deposits, cannabidiol research and development, real estate acquisitions and subsequent lease programs to alternative medicine dispensaries, and alternative medicine dispensary management services.

Forward-Looking Statements Statements in this press release constitute forward-looking statements within the meaning of federal securities laws. Such statements are based on our current beliefs and expectations and are inherently subject to significant business, economic and competitive uncertainties and contingencies, many of which are beyond our control. In addition, such forward-looking statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Potential risks and uncertainties include, but are not limited to, technical advances in the industry as well as political and economic conditions present within the industry. We do not undertake any obligation to update any forward-looking statement to reflect events or developments after a forward-looking statement was made.

Contact Information
Investor Relations:
Stephen Hart
Hayden IR
+1- 917-658-7878
hart@haydenir.com
Medbox: For more information on Medbox, please call (800) 762-1452.
SOURCE Medbox, Inc.